Efficacy and Safety of TD-1473 in Crohn's Disease
Public ClinicalTrials.gov record NCT03635112. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Multi-Center, Randomized, Double-Blind, Placebo˗Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Induction Therapy With 2 Doses of TD-1473 in Subjects With Moderately-to-Severely Active Crohn's Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A Phase 2 study to evaluate the efficacy, safety and tolerability of TD-1473 in subjects with moderately-to-severely active Crohn's Disease with up to 48 weeks of treatment.
Study identification
- NCT ID
- NCT03635112
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 167 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 19, 2018 (Actual)
- Primary completion
- Dec 30, 2021 (Actual)
- Completion
- Dec 30, 2021 (Actual)
- Last update posted
- Mar 13, 2023
2018 – 2021
United States locations
- U.S. sites
- 44
- U.S. states
- 19
- U.S. cities
- 42
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Theravance Biopharma Investigational Site | Birmingham | Alabama | 35233-2110 | — |
| Theravance Biopharma Investigational Site | Mobile | Alabama | 36688 | — |
| Theravance Biopharma Investigational Site | Scottsdale | Arizona | 85259-5499 | — |
| Theravance Biopharma Investigational Site | La Jolla | California | 92093 | — |
| Theravance Biopharma Investigational Site | Los Angeles | California | 90048 | — |
| Theravance Biopharma Investigational Site | Oakland | California | 94612 | — |
| Theravance Biopharma Investigational Site | Santa Monica | California | 90404 | — |
| Theravance Biopharma Investigational Site | Aventura | Florida | 33180 | — |
| Theravance Biopharma Investigational Site | Clearwater | Florida | 33765 | — |
| Theravance Biopharma Investigational Site | Hialeah | Florida | 33013 | — |
| Theravance Biopharma Investigational Site | Hollywood | Florida | 33021 | — |
| Theravance Biopharma Investigational Site | Largo | Florida | 33777 | — |
| Theravance Biopharma Investigational Site | Miami | Florida | 33135 | — |
| Theravance Biopharma Investigational Site | New Port Richey | Florida | 34653 | — |
| Theravance Biopharma Investigational Site | St. Petersburg | Florida | 33710 | — |
| Theravance Biopharma Investigational Site | Tampa | Florida | 33603 | — |
| Theravance Biopharma Investigational Site | Tampa | Florida | 33606 | — |
| Theravance Biopharma Investigational Site | New Lenox | Illinois | 60451 | — |
| Theravance Biopharma Investigational Site | Kansas City | Kansas | 66160 | — |
| Theravance Biopharma Investigational Site | Louisville | Kentucky | 40202 | — |
| Theravance Biopharma Investigational Site | Rockville | Maryland | 20850 | — |
| Theravance Biopharma Investigational Site | Brockton | Massachusetts | 02302 | — |
| Theravance Biopharma Investigational Site | Wyoming | Michigan | 49519 | — |
| Theravance Biopharma Investigational Site | St Louis | Missouri | 63110 | — |
| Theravance Biopharma Investigational Site | Las Vegas | Nevada | 89133 | — |
| Theravance Biopharma Investigational Site | Utica | New York | 13502 | — |
| Theravance Biopharma Investigational Site | Gastonia | North Carolina | 28504 | — |
| Theravance Biopharma Investigational Site | Greenville | North Carolina | 27834 | — |
| PMG Research of Salisbury | Salisbury | North Carolina | 28144 | — |
| Theravance Biopharma Investigational Site | Tulsa | Oklahoma | 74136 | — |
| Theravance Biopharma Investigational Site | Pittsburgh | Pennsylvania | 15212 | — |
| Theravance Biopharma Investigational Site | Uniontown | Pennsylvania | 15401 | — |
| Theravance Biopharma Investigational Site | Orangeburg | South Carolina | 29118 | — |
| Theravance Biopharma Investigational Site | Rock Hill | South Carolina | 29732 | — |
| Theravance Biopharma Investigational Site | Boerne | Texas | 78006 | — |
| Theravance Biopharma Investigational Site | El Paso | Texas | 79936 | — |
| Theravance Biopharma Investigational Site | Garland | Texas | 75044 | — |
| Theravance Biopharma Investigational Site | Harlingen | Texas | 78550 | — |
| Theravance Biopharma Investigational Site | Houston | Texas | 77058 | — |
| Theravance Biopharma Investigational Site | San Antonio | Texas | 78215 | — |
| Theravance Biopharma Investigational Site | San Antonio | Texas | 78229 | — |
| Theravance Biopharma Investigational Site | Southlake | Texas | 76092 | — |
| Theravance Biopharma Investigational Site | Spring | Texas | 77386 | — |
| Theravance Biopharma Investigational Site | Lansdowne Town Center | Virginia | 20176 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 134 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03635112, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 13, 2023 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03635112 live on ClinicalTrials.gov.